论文部分内容阅读
Ⅱ期临床研究显示，冠心病患者Ｐｈａｒｍａｃｙｃｌｉｃｓ公司的光致血管成形剂Ａｎｔｒｉｎ（ｍｏｔｅｘａｆｉｎ ｌｕｔｅｔｉｕｍ）对耐受性良好。 本品为可由远红外光激活的光敏感剂，可直接作用于心室，并能在动脉硬化组织中蓄积。同时，光纤维可由腹股沟小切口进入栓塞
Phase II clinical studies have shown that patients with coronary heart disease Pharmacyclics company photic angiogenesis agent Antrin (motexafin lutetium) was well tolerated. This product can be activated by far-infrared light-sensitive agent, can act directly on the ventricle, and can accumulate in atherosclerosis. At the same time, optical fibers can enter the embolization by a small incision in the groin